2020
DOI: 10.1007/s10008-020-04541-1
|View full text |Cite
|
Sign up to set email alerts
|

Carbon black-chitosan film-based electrochemical sensor for losartan

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(3 citation statements)
references
References 45 publications
0
3
0
Order By: Relevance
“…The sample preparation followed as described by Silva et . [46]. First, ten tablets of each sample were weighed to determine the average mass of one tablet.…”
Section: Methodsmentioning
confidence: 99%
“…The sample preparation followed as described by Silva et . [46]. First, ten tablets of each sample were weighed to determine the average mass of one tablet.…”
Section: Methodsmentioning
confidence: 99%
“…To combat this, carbon black (CB) nanoparticles have been proposed as electrode modifiers for cannabis seed oil, antihypertensive drugs, phenolic compounds, DNA, flavonoids, and metal analysis. Carbon black offers comparable results to other carbon nanostructured sensors [16][17][18][19][20][21][22][23] It is a commonly available carbon source with elemental carbon arranged in aggregates of fine particles from 3 -100 nm. The nanomaterial is often employed as thin film or electrode coating in conjunction with other nanoparticles and active materials.…”
Section: Introductionmentioning
confidence: 99%
“…It is also characterized by the availability of a large number of amino and hydroxylbased functional groups that can excellently serve for the covalent immobilization of biosensing elements by introducing a proper choice of reagent, for instance, glutaraldehyde, allowing the covalent bond formation or affinity conjugation with other functional components 28 . Thus far, chitosan-based electrochemical immunosensors have been applied in various applications according to their obvious performance [29][30][31][32][33] . However, using the chitosan-supported electrochemical biosensor as a handle in point-of-care clinical trials remains a challenge.…”
mentioning
confidence: 99%